I Spent 17 Years Charging Seniors $4,672 For Hearing Aids. Here's What I Never Told Them.
A former top audiologist breaks her silence on the biggest markup in modern medicine — and reveals the device her own patients are now wearing instead.
If you've ever sat across a desk from an audiologist, heard the price of hearing aids, and driven home with nothing —
I need you to read this.
Not because I'm selling you something.
Because I was one of those audiologists.
For 17 years, I sat across from people just like you. I watched their faces fall when I showed them the price. I watched them say "I'll think about it." I watched them leave.
And I smiled and handed them a brochure.
I'm not doing that anymore.
What I'm about to share with you is what I should have said in that office but couldn't — because the entire business model I was part of depended on you not knowing it.
Read this before you spend another dollar on hearing. Before you book another clinic appointment. Before you buy another device off Amazon that you'll return in two weeks.
Everything changes once you understand what I'm about to show you.
Who I Am — And Why I'm Telling You This Now
My name is Dr. Rachel Simmons.
I'm a board-certified audiologist with a doctorate from the University of Cincinnati. I spent 17 years in clinical audiology — first at a major clinic chain with locations across six states, then at my own private practice in Columbus, Ohio.
I've fitted thousands of patients with hearing aids.
I've sat in more soundproof booths than I can count.
I've written more prescriptions for Phonak, Oticon, Starkey, and Widex than most audiologists fit in a career.
And I was good at my job.
For most of those 17 years, I told my patients that they had two real choices: the hearing aids I prescribed — starting at $3,400, averaging $4,672, going as high as $7,000 for a pair — or the drugstore devices that barely work.
I said it with a straight face.
I said it because I believed it.
And I said it because that's what the business model required.
It took one patient to make me stop.
The Patient I Couldn't Forget
Her name was Margaret Holloway.
She was 71 years old. Retired schoolteacher from Dayton. Thirty-two years in a third-grade classroom — loud, beautiful, chaotic — and her hearing had been paying the price ever since.
She came in with her daughter, Susan.
They'd driven 47 minutes for the appointment. Susan had taken the morning off work.
During the evaluation, Margaret's audiogram confirmed what she already knew: moderate high-frequency hearing loss in both ears. The exact type that makes conversations in noisy rooms nearly impossible. The exact type that makes grandchildren's voices sound like they're coming from underwater.
She asked me, carefully, what it would cost.
I told her our entry-level pair started at $3,400.
She nodded slowly.
"Do you have a payment plan?"
I told her we offered 12 months at zero interest if she qualified.
She looked at Susan. Susan looked at her hands.
"I'm on Social Security," Margaret said. "My fixed income is — I was trying to save up before I came in. We have about $300 put aside."
I remember exactly what I said.
"I understand. A lot of our patients find that once they experience the difference in their quality of life, they find a way to make it work."
She thanked me.
She shook my hand.
She walked out.
I stood at the window of my office and watched her and Susan walk to the car. They sat there for a moment before Susan started the engine. I don't know what they said.
That night I couldn't sleep.
Not because of Margaret specifically. Because of the eleven Margarets I'd seen that week. The fourteen the week before. The ones I'd seen for seventeen years.
I'd always told myself: this is the price of precision-manufactured medical devices. This is what hearing technology costs.
That night, for the first time, I decided to find out if that was actually true.
What I Found at the Conference in Chicago
Three months after Margaret's appointment, I flew to Chicago for the International Hearing Technology Summit.
I almost didn't go. I'd been to dozens of these conferences. It was always the same: hearing aid manufacturers showing their latest iterations, audiologists collecting continuing education credits, dinner and drinks.
This year was different.
On the second afternoon, a researcher named Dr. Klaus Brenner from the Hanover Institute of Acoustic Engineering stood up and gave a presentation that quietly destroyed everything I thought I knew about hearing aid pricing.
He put a slide on screen.
It showed the component breakdown of a premium prescription hearing aid — the kind I prescribed daily at $4,672 a pair.
The chip that does the actual hearing work — the digital signal processor (DSP), the component that identifies speech frequencies and separates them from background noise — costs, at clinical volume, between $100 and $280 per unit to manufacture.
I leaned forward in my seat.
He went through the rest of the breakdown. The microphone housing. The receiver. The enclosure. The eartips. Everything that makes up the physical device.
Total manufacturing cost per device: $140 to $320.
I raised my hand.
"So the technology itself — the speech processing — costs $140 to $320. And we're charging $4,672. Where is the rest going?"
He looked at me over his glasses.
"To you," he said. "And your office. And the brand. And the distributor. And the regional sales representative. And the television advertisements that made your patients trust the name before they sat down in your chair."
The room was quiet.
He clicked to the next slide.
"You are not charging for technology. You are charging for a delivery system."
The Real Reason Hearing Aids Cost $4,672 — And Why It Has Nothing To Do With The Technology
Here's what I learned that night in Chicago — and what I should have known years earlier.
The prescription hearing aid system is not priced by technology.
It's priced by infrastructure.
When you pay $4,672 at a clinic, you are paying for:
My salary. An audiologist with a doctorate earns $80,000–$130,000 per year. That salary is built into every pair of aids I sell.
The office. Commercial medical office space in a metro area: $8,000–$15,000 per month.
The brand. Phonak, Oticon, Starkey — companies that spend tens of millions on television advertising specifically so that when you sit in my chair, you trust the name.
The distributor. Every brand has a regional distribution network. Their margins are built into the retail price.
The fitting appointments. Three to five appointments per patient, each billed as part of the bundled "service."
The leather chairs in the waiting room.
I'm not being sarcastic. I genuinely had leather chairs. You paid for them.
The chip inside the $4,672 device — the only component that actually makes you hear better — costs $280.
That chip is identical in class and function to what is now available in over-the-counter hearing devices.
Think of it like aspirin.
The active ingredient in a $12 name-brand bottle of aspirin is 325 milligrams of acetylsalicylic acid. The active ingredient in the $2 store brand is 325 milligrams of the same compound.
Same drug. Same dose. Different box. Different price.
You've been paying $4,672 for a very expensive box.
And here's what makes this worse.
The FDA changed the rules in October 2022. They legalized over-the-counter hearing aids — real, speech-processing hearing devices, not sound amplifiers — for adults with mild-to-moderate hearing loss.
No prescription required.
No audiologist required.
No appointment, no fitting, no waiting room, no leather chairs.
The technology is identical. The delivery system is gone.
And almost nobody told you.
Why Everything You've Tried Before Didn't Work
Now that you understand what's really happening, let me show you the four options you actually have.
The right technology. The wrong price. For patients who can afford it and want the support of ongoing audiologist care, this is a legitimate path. But for the 25 million Americans with untreated hearing loss — most of whom walked out of a clinic exactly like mine after seeing the price — this option failed them before they ever started.
A genuine step in the right direction. Costco uses real speech-processing chips and their prices are substantially lower than private clinics. But you're locked to their locations, their scheduling, and their staff. Every adjustment requires an in-store appointment. If you don't live near a Costco with a hearing center — and most rural Americans don't — this option isn't really available to you.
This is not a hearing aid. I cannot stress that enough.
A sound amplifier is a microphone, a speaker, and a volume dial. It has no speech-processing chip. It boosts all frequencies equally — which means the restaurant clatter, the AC hum, the chair scraping, and the voice you're trying to hear all get louder at exactly the same rate.
It doesn't help. It makes the problem worse. And it leaves you more skeptical of everything else.
If you tried one of these and put it in a drawer, that is the correct response. You didn't fail at hearing aids. You bought something that isn't one.
This is where the 2022 FDA ruling changed everything.
For the first time, legitimate speech-processing technology — the same class of dual-channel DSP chip used in prescription aids — is available without a prescription, without an audiologist, and without the clinic's overhead built into the price.
This is what I should have been able to recommend to Margaret.
Let me tell you what I found when I went looking.
The Technology That Actually Works — And Where It Comes From
After Chicago, I spent four months researching every over-the-counter device on the market.
I understood the engineering requirements from the inside. I knew what a real speech-processing chip does. I knew the difference between a device that selectively amplifies human speech frequencies (1,000–4,000 Hz) and one that simply turns everything up.
Most of what I found was junk.
Amplifiers in plastic shells with marketing copy that used words like "crystal clear" and "revolutionary."
But there was one device that stopped me.
It was called Amplihear.
What distinguished it immediately: it documented genuine dual-processing architecture — two separate processing channels, one dedicated to isolating speech frequencies, one dedicated to actively suppressing everything outside that range.
This is precisely what a $4,672 prescription aid does.
Not volume. Clarity.
The device used German-engineered signal processing — the same acoustic engineering tradition behind Siemens Signia, the world's largest hearing aid manufacturer.
It came with a wireless charging case — meaning no zinc-air batteries. No size 312s, no tweezers, no fumbling at 6 AM before you can hear anything. You put them in the case at night. In the morning, they're ready.
It had Bluetooth audio streaming — phone calls, television, music streamed directly to the aids.
It included built-in tinnitus masking tones — relevant for the majority of hearing loss patients who also have tinnitus.
And it was priced at under $100.
I almost laughed.
I've been writing prescriptions for $4,672 hearing aids for 17 years. The core technology — the part that actually does the hearing — costs between $100 and $280 to manufacture. And here was a device with dual-processing, wireless charging, and Bluetooth, for under $100.
I ordered a pair.
What Happened When I Tried Them
I want to be precise here, because I'm a scientist and vague testimonials irritate me.
I have mild hearing loss in my left ear from 15 years of calibrating and testing equipment at clinical volumes. It's occupational. I've been managing it.
I put Amplihear in on a Thursday evening and went to dinner with my husband at a restaurant we go to regularly. It's a good Italian place — wood floors, high ceilings, exactly the kind of ambient noise environment that hearing loss patients describe as impossible.
His voice came forward.
Not louder. I want to be very clear about that distinction, because it's the entire point.
His voice came forward. The restaurant noise — the table next to us, the kitchen, the music — fell back. I wasn't straining. I wasn't leaning toward him. I was just hearing him.
After dinner, I put the aids in the charging case.
My prescription hearing aids go in with a pair of tweezers and a size-312 zinc-air battery.
The Amplihear case sat on my nightstand. I put them in. The case closed. That was it.
I sat on the edge of the bed for a moment.
Mine cost $4,672.
I was not prepared for how angry that made me.
Margaret Called Me Six Months Later
I hadn't heard from her since that appointment.
She'd found my number from the clinic's old contact page. She called on a Tuesday afternoon in November.
"Dr. Simmons. It's Margaret Holloway. You probably don't remember me — "
I remembered her immediately.
She told me she'd found Amplihear through a Facebook group for people over 65. Someone in the group had posted about it. She'd been skeptical — the price seemed too low. She'd read every review she could find. She'd ordered them on a Thursday. They arrived Saturday.
She told me she wore them to Sunday dinner at her daughter's that weekend.
Her grandson — seven years old, name is Thomas — had been telling a story about something that happened at school. She caught every word. She asked a follow-up question. Thomas stopped talking mid-sentence. He looked at her.
"Grandma, you heard that?"
"Yes," she said. "Every word."
He climbed up next to her on the couch and started the story over from the beginning.
She was quiet for a moment on the phone.
"I've been waiting eleven years to hear that boy clearly," she said. "I just wanted to tell someone who would understand why that mattered."
I understood.
What 12,637 People Have Found Since Then
Margaret was not an exception.
Amplihear now has more than 12,637 verified customers. Ninety-seven percent of them say they would recommend it to a friend or family member.
There is also research beyond the device itself that I want you to understand.
A landmark study from Johns Hopkins Bloomberg School of Public Health found that untreated hearing loss is associated with a 32% increased risk of dementia.
Not because hearing loss causes dementia directly — but because when the brain works overtime to parse degraded audio signals, it diverts cognitive resources from memory, processing, and executive function. Every year of delay has a measurable cost that goes beyond missing conversations.
This is not a quality-of-life issue. This is a brain health issue.
And it's preventable.
Here's What Amplihear Does — In Plain English
I'm going to explain this the way I wish someone had explained it to my patients.
Your inner ear contains hair cells called stereocilia. They're arranged by frequency — high-frequency cells at one end of the cochlea, low-frequency cells deeper in.
Age-related hearing loss destroys the high-frequency cells first.
The frequencies they handle: 1,000 Hz to 4,000 Hz.
That is precisely the frequency range where human speech lives. Consonants. The edges of words. The difference between "cats" and "hats." The clarity of a seven-year-old's voice.
When those cells are gone, they don't regenerate. The signal doesn't get to the brain clearly.
A cheap amplifier turns up the volume on everything — including every frequency that isn't speech. This makes noisy environments worse, not better.
Amplihear's dual-processing technology does something different.
Identifies the 1,000–4,000 Hz speech band and selectively amplifies it.
Detects and suppresses everything outside that range — ambient noise, background clatter, environmental hum.
The result: voices come forward. Everything else falls back.
This is identical to what the $4,672 device in my clinic does.
The difference is that Amplihear charges wirelessly, streams Bluetooth audio from your phone, and costs under $100 — because there is no clinic, no audiologist, no distributor, and no waiting room.
Why You Can Now Access This Without a Prescription
In October 2022, the FDA finalized rules allowing hearing aids to be sold over-the-counter to adults with mild-to-moderate hearing loss.
No audiologist required. No prescription. No fitting appointment.
This regulatory change was the single most significant shift in hearing care access in decades.
Amplihear was built specifically to take advantage of it — bringing the same speech-processing chip class as prescription aids to a direct-to-consumer model with none of the clinic overhead.
The technology has existed for decades. The access hadn't. Now it does.
The Seniors Hearing Association Program — And Why You May Not Have to Pay Full Price
Before I tell you how to get Amplihear, I need to tell you about something I only learned recently.
The Seniors Hearing Association — a nonprofit advocacy organization focused on expanding hearing care access for Americans on fixed incomes — has partnered with Amplihear on a program called the Hearing Access Initiative.
The program is simple: qualifying seniors receive a subsidized access price, with the association covering the difference between the retail price and the access price.
The program is funded quarterly. Slots are limited and allocated on a first-come basis.
To see if you qualify — and to find out what your access price would be — you need to complete a short eligibility check. It takes 60 seconds.
If you don't qualify for the program, you lose 60 seconds. If you do — and most people reading this will — you'll be looking at a price that makes the 90-day trial an obvious decision.
What Real People Are Saying
"I'd been waiting two years to do something about my hearing because the clinic quoted me $4,100. My daughter found Amplihear. I was skeptical — under $100 seemed impossible. Three weeks later, I'm at Sunday dinner actually following the conversation. My granddaughter looked at me and said 'Grandma, you seem different.' I told her I could finally hear her. She hugged me for a long time. I hadn't cried in years. I cried then."
"Went to Miracle-Ear. $4,800 quote. Went home. Tried two Amazon devices — one whistled, one made everything so loud I couldn't stand it. Both went in a drawer. My neighbor told me about Amplihear. I figured I'd lost enough money already, what's another few bucks. They arrived in two days. I've been wearing them for three months. My wife stopped coming to tell me things in person because she can just call from the other room again. That sounds small. It isn't."
"I'd had Phonak aids for four years. They work fine. But changing those batteries every five days with arthritis in both hands was making me dread wearing them. I read about Amplihear and figured I'd try it. I put them in the case the first night and forgot about them. In the morning they were charged. I have not thought about batteries since. And for $89 versus $4,200 — I don't understand why I waited."
This Is Not the Same as What You Tried Before
I want to address this directly.
If you tried an Amazon amplifier and it made everything louder without making anything clearer — that was not a hearing aid. That was a speaker attached to a microphone. It cannot do what Amplihear does. It doesn't have the chip.
If you were quoted $4,000–$5,000 at a clinic and walked out — you were quoted the right technology at an unjustifiable price. The technology is now available without the overhead.
If you've been waiting for the price to come down — the FDA changed the rules in 2022. The price came down. This is that moment.
The Guarantee That Makes This Decision Simple
Amplihear comes with a 90-day money-back guarantee.
Not 30 days. Ninety.
Three months to wear them at your own kitchen table, at Sunday dinner, at church, on the phone, at the restaurant you've been avoiding.
If after 90 days you don't hear better — return them. Full refund. No questions.
At under $100 with a 90-day return window, the only question is: what do you have to lose by finding out?
Wear Amplihear for a full 90 days. If you don't hear better — return them for a complete refund. No questions. At under $100, the only risk is the 60 seconds it takes to check your eligibility.
One More Thing — About Waiting
I've watched what waiting does.
A patient who walks out of my office at 68 with untreated moderate hearing loss does not improve. The loss deepens. The compensatory behaviors become habits. The social withdrawal accelerates. The cognitive load compounds.
The Johns Hopkins research is clear. Every year of untreated hearing loss has a measurable cost — not just in missed conversations, but in cognitive resilience.
Margaret waited eleven years.
She spent eleven years nodding along at family dinners, letting calls go to voicemail, excusing herself from social events that were too loud to navigate.
She found Amplihear on a Thursday. By Sunday, her grandson was starting stories over from the beginning because he knew, for the first time, that his grandmother was really hearing them.
Eleven years.
Don't do eleven years.
Check If You Qualify for the Seniors Hearing Association Program
The Seniors Hearing Association's Hearing Access Initiative has a limited number of subsidized access slots available for the current quarter.
To see if you qualify — and to see what your access price would be — click below to take the 60-second eligibility check.
Most people who have read this article will qualify.
If you don't, you've lost 60 seconds.
If you do, you'll be looking at a price and a 90-day guarantee that makes the next step obvious.
The Seniors Hearing Association Hearing Access Initiative is a nonprofit-funded subsidy program for qualifying seniors. Pricing shown after eligibility confirmation reflects the subsidized access rate. Amplihear is designed for adults with mild-to-moderate hearing loss. Consult a physician for severe hearing loss. 90-day money-back guarantee applies to all purchases. Fast 2–3 day shipping from US warehouse.
Dr. Rachel Simmons, Au.D., practiced clinical audiology for 17 years before leaving private practice. She writes about hearing health, pricing transparency in medical devices, and patient access. This article is editorial in nature and reflects her personal clinical experience and research.
This article is for educational and informational purposes only and does not constitute medical advice. Results described reflect individual experiences and may vary. Always consult a qualified audiologist or physician for a clinical hearing evaluation. Amplihear is designed for adults with mild-to-moderate hearing loss and is not a substitute for professional audiological care for severe hearing loss.